Susceptibility to Cardiac Ischemia/Reperfusion Injury Is Modulated by Chronic Estrogen Status
- 1 September 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 40 (3) , 420-428
- https://doi.org/10.1097/00005344-200209000-00011
Abstract
The purpose of this study was to test whether the susceptibility of the heart to ischemia/reperfusion injury is modulated by the chronic estrogen status, i.e., increased with estrogen deficiency and attenuated by pharmacologic estrogen supplementation. In addition, the study tested whether estrogen-dependent changes in mechanical function are associated with alterations of cardiac high-energy phosphate metabolism. Rats were ovariectomized, not ovariectomized, or ovariectomized and treated with subcutaneous estrogen pellets (1.5 mg/21 d) (n = 8–11 per group). Three weeks later, hearts were isolated and perfused isovolumically under constant perfusion pressure conditions. Hearts were subjected to 15 min of total global ischemia (37°C) and 30 min of reperfusion. Simultaneous [31P] nuclear magnetic resonance spectra were recorded throughout this protocol to monitor changes in ATP, phosphocreatine, and inorganic phosphate content. Whereas preischemic values for heart rate, end-diastolic pressure, and coronary flow were not different among groups, left ventricular developed pressure was slightly but significantly decreased in the estrogen-treated group (p < 0.05). However, treated hearts showed improved recovery of left ventricular developed pressure on reperfusion (89 ± 4% in control rats, 70 ± 8% in ovariectomized hearts, and 114 ± 9% of preischemic values in estrogen-treated rats). However, changes in ATP, phosphocreatine, and inorganic phosphate during ischemia were as previously described and were unaffected by chronic estrogen status. In conclusion, in the isolated buffer-perfused rat heart, estradiol treatment caused improved functional recovery after ischemia/reperfusion injury. This improvement, however, did not include preservation of high-energy phosphate metabolism. Other potential mechanisms include an anti-oxidant activity of 17β-estradiol-and estrogen-induced alterations in glucose metabolism.Keywords
This publication has 36 references indexed in Scilit:
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisNew England Journal of Medicine, 2000
- Enhancement of Post-ischemic Myocardial Function by Chronic 17β-Estradiol Treatment: Role of Alterations in Glucose MetabolismJournal of Molecular and Cellular Cardiology, 1999
- Multiple Mechanisms are Involved in the Acute Vasodilatory Effect of 17β-Estradiol in the Isolated Perfused Rat HeartJournal of Cardiovascular Pharmacology, 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Myocardial Protection of Contractile Function After Global Ischemia by Physiologic Estrogen Replacement in the Ovariectomized RatJournal of Molecular and Cellular Cardiology, 1997
- Protection from Myocardial Reperfusion Injury by Acute Administration of 17β-EstradiolJournal of Molecular and Cellular Cardiology, 1996
- Preservation of Left Ventricular Mechanical Function and Energy Metabolism in Rats After Myocardial Infarction by the Angiotensin-Converting Enzyme Inhibitor QuinaprilJournal of Cardiovascular Pharmacology, 1996
- Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction.Journal of Clinical Investigation, 1995
- Verapamil attenuates ATP depletion during hypoxia: 31P NMR studies of the isolated rat heartJournal of Molecular and Cellular Cardiology, 1989
- Sex hormone modulation of ventricular hypertrophy in sinoaortic denervated rats.Hypertension, 1988